Kidney Research and Clinical Practice

Search

Page Path

HOME
Search

Original Articles

Metabolic risks in living kidney donors in South Korea: Eunjeong Kang, Jina Park, Hyo Jeong Kim et al.; Kidney Res Clin Pract. 2021;40(4):645-659. Published online October 12, 2021; DOI: https://doi.org/10.23876/j.krcp.20.271
Cited By 3; Full text PubReader ePub PDF Supplementary Material

Hyperuricemia is a risk factor for the progression to end-stage renal disease in minimal change disease: Su Hyun Song, Tae Ryom Oh, Hong Sang Choi et al.; Kidney Res Clin Pract. 2021;40(3):411-418. Published online September 9, 2021; DOI: https://doi.org/10.23876/j.krcp.20.220
Cited By 4; Full text PubReader ePub PDF

Physicians’ perceptions of asymptomatic hyperuricemia in patients with chronic kidney disease: A questionnaire survey: Ran-hui Cha, Su Hyun Kim, Eun Hui Bae et al.; Kidney Res Clin Pract. 2019;38(3):373-381. Published online September 30, 2019; DOI: https://doi.org/10.23876/j.krcp.19.007
Cited By 4; Full text PubReader PDF Supplementary Material

Case Reports

Use of dapagliflozin in patients with advanced diabetic kidney disease: Hyun Sun Park, Youn Joo Jung, Dong-Young Lee, Kyoung Hyoub Moon, Beom Kim, Hae Won Kim; Kidney Res Clin Pract. 2018;37(3):292-297. Published online September 30, 2018; DOI: https://doi.org/10.23876/j.krcp.2018.37.3.292
Cited By 5; Full text PubReader PDF

Original Articles

Relationship between serum uric acid and mortality among hemodialysis patients: Retrospective analysis of Korean end-stage renal disease registry data: Chang Seong Kim, Dong-Chan Jin, Young Cheol Yun, Eun Hui Bae, Seong Kwon Ma, Soo Wan Kim; Kidney Res Clin Pract. 2017;36(4):368-376. Published online December 31, 2017; DOI: https://doi.org/10.23876/j.krcp.2017.36.4.368
Cited By 38; Full text PubReader PDF Supplementary Material

Renoprotective effects of febuxostat compared with allopurinol in patients with hyperuricemia: A systematic review and meta-analysis: Sollip Kim, Hyun-Jung Kim, Hyeong-Sik Ahn et al.; Kidney Res Clin Pract. 2017;36(3):274-281. Published online September 30, 2017; DOI: https://doi.org/10.23876/j.krcp.2017.36.3.274
Cited By 34; Full text PubReader PDF Supplementary Material

Hyperuricemia as a marker for progression of immunoglobulin A nephropathy: Su-Ji Kim, Jung-Hoon Kim, Hyo-Wook Gil, Jong-Oh Yang, Eun-Young Lee, Sae-Yong Hong; Kidney Res Clin Pract. 2012;31(3):186-191. Published online July 20, 2012; DOI: https://doi.org/10.1016/j.krcp.2012.07.003
Cited By 4; Full text PubReader PDF

Volume 42, No. 6

Kidney Research
and
Clinical Practice

Print ISSN: 2211-9132
Online ISSN: 2211-9140

Impact Factor

3.0

MOST VIEWED MOST CITED

5,953	How should we treat acute kidney injury caused by renal congestion?
8,756	Kidney transplantation in highly sensitized recipients
10,925	Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options
6,221	When and why to start continuous renal replacement therapy in critically ill patients with acute kidney injury
2,175	Serum and urine metabolomic biomarkers for predicting prognosis in patients with immunoglobulin A nephropathy

Cited By 53	Trends in epidemiologic characteristics of end-stage renal disease from 2019 Korean Renal Data System (KORDS)
Cited By 23	Implications of oxidative stress in chronic kidney disease: a review on current concepts and therapies
Cited By 17	Intestinal microbiota and kidney diseases
Cited By 12	Pediatric acute kidney injury: new advances in the last decade
Cited By 12	Association between copeptin levels and treatment responses to hypertonic saline infusion in patients with symptomatic hyponatremia: a prospective cohort study

Editorial Office: #301, (Miseung Bldg.) 23, Apgujenog-ro 30-gil, Gangnam-gu, Seoul 06022, Korea
Tel: +82-2-3486-8736 Fax: +82-2-3486-8737 E-mail: registry@ksn.or.kr

Copyright © 2023 by The Korean Society of Nephrology.